Billionaire entrepreneur and investor Mark Cuban thinks The united states’s healthcare business is damaged, and he’s no longer mincing phrases about it.
“No person seems to be on the monetary aspect of healthcare and says, ‘That is how it must paintings,’” Cuban mentioned in this week’s episode of the Fairness podcast. “While you cross to the physician and also you get a prescription . . . you don’t have any concept what the associated fee to you goes to be. You don’t know if you’ll be able to manage to pay for it or no longer.”
The previous “Shark Tank” host and minority proprietor of the Dallas Mavericks basketball crew defined the foundation of the issue: maximum drug costs these days are set by means of pharmacy get advantages managers (PBMs), or 3rd events that arrange prescription drug methods. Cuban mentioned drug costs are opaque by means of design.
That’s precisely why he introduced Value Plus Medicine in 2022 — to tug again the curtain on drug pricing, deliver down prices to the typical shopper, and disrupt the standard pharmacy business.
“They worth to marketplace; we worth based totally off of value,” he mentioned.
The adaptation is stunning. For instance, a generic chemotherapy drug may value 1000’s over-the-counter at a pharmacy, while it will value “$21 from Value Plus Medicine,” Cuban mentioned.
Cuban’s manner is hugely other from how medicine are historically priced within the U.S. As its title suggests, Value Plus Medicine sells meds immediately to shoppers at a clear worth – the producer’s value, plus a fifteen% markup, plus a $5 pharmacy charge, plus delivery.
Techcrunch match
San Francisco
|
October 27-29, 2025
“And we’re including the power to select it up in a neighborhood pharmacy,” Cuban added.
To know why Cuban’s type is disruptive, it is helping to understand why medicine value such a lot within the first position. The business has defended its apply of overcharging for drugs within the U.S. – which is without doubt one of the most effective high-income international locations whose govt doesn’t set or negotiate drug costs – by means of arguing that with out the inducement of excessive income, corporations couldn’t make investments the billions of bucks had to deliver new medicine to marketplace.
However critics argue that costs are set to maximise benefit and aren’t immediately tied to R&D prices. One 2021 find out about discovered that earnings from the highest 20 best-selling medicine by myself used to be sufficient for corporations to wring a go back from their R&D prices with billions left over.
Cuban additionally identified one more reason that drug costs skyrocket within the U.S.: synthetic shortages. “Imagine it or no longer, at the moment, there are such things as pediatric most cancers medicine, Pitocin, sterile water, [and] this lengthy checklist of gear I will’t even pronounce proper, that cross in brief provide since the producers need them to head in brief provide, as a result of that’s how they jack up the associated fee,” Cuban mentioned.
Whilst there’s restricted direct proof of intentional profiteering, it’s true that all over shortages, costs upward push considerably.
His solution? Construct his personal manufacturing facility. Cuban’s has a producing plant in Dallas that’s “all robotics pushed.”
“We created this manufacturing facility the place we will be able to flip over a brand new drug in 4 hours and send it out to hospitals,” he persevered. “And so we’re beginning to assault the ones shortages.”
Whilst delivery medicine to sufferers has razor-thin margins, different sides of Value Plus Medicine, like drug production, are extra winning and lend a hand the trade paintings towards profitability. Production could also be in a different way to problem the drug provide chain.
However Cuban’s technique is going past simply providing inexpensive medicine — he says he’s refusing to play by means of the principles solely. “Everyone used to be pronouncing . . . you’ll be able to’t combat those large corporations, the insurance coverage carriers, the PBMs,” he mentioned. “I’m like, ‘Neatly, I simply received’t paintings with them. I’m no longer going to paintings the best way they need to do it, as a result of that’s no longer what’s ultimate aligned for sufferers.”
Even Amazon, Cuban famous, fell into this entice. The tech massive has partnered with partnered with PBMs thru Amazon Pharmacy, however that places the massive tech company at a drawback as it’s nonetheless “beholden to PBMs.”
His recommendation to founders looking to take down incumbents?
“Don’t be depending on them,” he mentioned. “As a result of if I have been 25 and beginning this trade, I most probably would paintings in the course of the pharmacy get advantages managers as a result of that’s the place the cash is. All of healthcare is principally an arbitrage. How can I simply get a small share of a $5 trillion marketplace thru generation, pricing, no matter it can be?”
“Once I began out, any person informed me this: ‘While you run with the elephants, there’s the fast and the useless,’” Cuban mentioned. “You’ve were given to be fast, otherwise you’re going to be useless, and so that you’ve were given to be lean, imply. You’ve were given as a way to adapt. You’ve were given as a way to zig and zag and at all times search for techniques to only do higher, as it’s the entire Innovator’s Quandary factor for [the incumbents], proper? They’ve were given to offer protection to their legacy companies, however they may be able to’t transfer as briefly. They are able to’t react as briefly, and in order that’s at all times going to provide the founder an edge.”
